Article Text

PDF
Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis
  1. M Daniell,
  2. M Constantinou,
  3. H T Vu,
  4. H R Taylor
  1. Centre for Eye Research Australia, University of Melbourne and Corneal Clinic, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
  1. Correspondence to: Dr Mark Daniell Centre for Eye Research Australia, University of Melbourne, Corneal Clinic, Royal Victorian Eye and Ear Hospital, Locked Bag 8, East Melbourne 8002, Australia; daniellm{at}ozemail.com.au

Abstract

Aim: To evaluate the efficacy, safety, and therapeutic effect of topical ciclosporin A 0.05% as a steroid sparing agent in steroid dependent allergic conjunctivitis.

Methods: Prospective, randomised, double masked, placebo controlled trial comparing signs, symptoms, and the ability to reduce or stop concurrent steroid in steroid dependent atopic keratoconjunctivitis and vernal keratoconjunctivitis using 0.05% topical ciclosporin A compared to placebo. Steroid drop usage per week (drug score), symptoms, and clinical signs scores were the main outcome measures.

Results: The study included an enrolment of 40 patients, 18 with atopic keratoconjunctivitis and 22 with vernal keratoconjunctivitis. There was no statistical significant difference in drug score, symptoms, or clinical signs scores between the placebo and ciclosporin group at the end of the treatment period. No adverse reactions to any of the study formulations were encountered.

Conclusions: Topical ciclosporin A 0.05% was not shown to be of any benefit over placebo as a steroid sparing agent in steroid dependent allergic eye disease.

  • AKC, atopic keratoconjunctivitis
  • CsA, ciclosporin A
  • IgE, immunoglobulin E
  • RCT, randomised controlled trial
  • VKC, vernal keratoconjunctivitis
  • topical ciclosporin A
  • atopic keratoconjunctivitis
  • vernal keratoconjunctivitis
  • steroid dependent allergic conjunctivitis
  • AKC, atopic keratoconjunctivitis
  • CsA, ciclosporin A
  • IgE, immunoglobulin E
  • RCT, randomised controlled trial
  • VKC, vernal keratoconjunctivitis
  • topical ciclosporin A
  • atopic keratoconjunctivitis
  • vernal keratoconjunctivitis
  • steroid dependent allergic conjunctivitis

Statistics from Altmetric.com

Footnotes

  • The authors have no commercial interest in the findings presented in this paper.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • BJO at a glance
    Creig Hoyt